Answers are grounded in this paper and cite their sources.
We present an MDM2 degrader that functions through the non-covalent tethering of ubiquitin to MDM2. Chimeric degraders comprising a nuclear localization sequence, M1-linked diubiquitin, and an MDM2-targeting ligand markedly reduced intracellular MDM2 levels, establishing a non-enzymatic platform of targeted ubiquitination that enables fine control of intranuclear protein stability and degradation.
No takes yet. Share an insight, caveat, or question.
Furuhata et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: